banter and General Discussion, page-7006

  1. 16,290 Posts.
    lightbulb Created with Sketch. 6189
    Not sure of the financial modelling Doc has relied upon here- but probably is a former analyst as well.

    Well based on his financial modelling yesterday over on his stock where he claimed $7m revenue per month equates to "basically $2 million per week" I think he needs a new calculator

    .... and now today we hear again that the RMAT designation is no big deal .... only 86 RMAT's issued from 219 applications so I guess all those that were rejected shouldn't be that worried ? I wonder why the huge global pharma companies even bother to apply for an RMAT ? lol


    Nothing Mesoblast does seems to be worthwhile according the naysayers .... strange to say the least ?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.62
Change
-0.060(3.58%)
Mkt cap ! $2.063B
Open High Low Value Volume
$1.67 $1.68 $1.62 $8.379M 5.142M

Buyers (Bids)

No. Vol. Price($)
3 76559 $1.62
 

Sellers (Offers)

Price($) Vol. No.
$1.62 676 1
View Market Depth
Last trade - 16.10pm 03/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.